Clinical Trials Browser

Phase 1 × Surveys and Questionnaires × Tumor-Agnostic × Clear all

NCT02095054 2021-04-01

Regorafenib and Cetuximab in Patients With Advanced Malignancy

Phase 1 Completed

Neoplasm Metastasis